← The Wire·Consumer·

Aurora asks Alberta regulator to review Curaleaf hostile-bid disclosure

Aurora Cannabis has asked Alberta’s securities regulator to review alleged deficiencies in Curaleaf’s disclosure for its hostile bid. The filing creates a regulatory hurdle for Curaleaf’s offer and puts the adequacy of the bid materials before the commission.

PR NEWSWIRE / FILE

The story

Aurora Cannabis said it has applied to the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws in connection with Curaleaf’s hostile bid. Aurora intends to argue that Curaleaf’s circular contains several deficiencies affecting Aurora shareholders.

The dispute moves the takeover contest beyond direct shareholder solicitation and into securities-law review. The application concerns the bid’s disclosure materials, rather than the operating performance of Aurora’s cannabis business.

Aurora is the company seeking regulatory relief, while Curaleaf is the bidder whose circular is being challenged. The concrete mechanism is the Alberta commission’s ability to require compliance with applicable disclosure requirements before the bid process can proceed on its current footing.

The extent of the alleged deficiencies and the regulator’s response are not established here. The next developments are the Alberta Securities Commission’s handling of the application and any resulting order or timetable affecting Curaleaf’s circular and hostile bid.

Our read · Wed, Sep 23

Aurora Cannabis (ACB) asked Alberta’s regulator to review alleged deficiencies in Curaleaf’s hostile-bid circular.

Why. The immediate consequence is procedural: a regulator could require changes to Curaleaf’s circular, extending uncertainty around the bid without yet changing Aurora’s operations. Aurora’s older financial profile—$221.3M in revenue, down 9.8% year over year, and a -776.2% net margin—makes the takeover process material, but those figures do not resolve the disclosure dispute.

Both cases

The case it holdsAurora’s application could force corrective disclosure or delay Curaleaf’s hostile bid, giving shareholders more information before deciding on the offer.
The case it breaksThe case for a stronger read is limited because no regulatory order has been issued and the alleged disclosure deficiencies are not detailed here.

What could change this view: The Alberta Securities Commission may reject the application or allow the bid to proceed without requiring material changes to Curaleaf’s circular.

ACB stock page →
Your side is graded privately against closes after 10 trading days. Research, not advice.

Who reported it · 1

Keep reading

Latest on the Wire

Fed releases October meeting minutes three weeks after policy decisionAnthropic Said to Guide IPO Pricing Above Market RangeXi gives Trump a rare hug at Shenzhen airport as US-China tone softensLagarde says she will leave ECB early to counter election misinformationRansomware group The Gentlemen reportedly lists Nvidia for a leakContinue on the Wire →

Top this week

Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookNvidia interim CEO Colette Kress faces first earnings test after HuangNvidia CEO Jensen Huang reportedly resigns as US-China tensions riseNvidia CFO Colette Kress to serve as interim CEO after Jensen Huang
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.

About this report

Reported by PR Newswire as Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure, . Who answers for this

The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →

Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →